Vascular Biogenics Ltd. Announces $24 Million Registered Direct Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
VBL Therapeutics (VBLT) Moves Sharply Off Morning Lows
June 7, 2016 10:20 AM EDTVBL Therapeutics (NASDAQ: VBLT) is moving sharply off morning lows following selling pressure amid its 4.36M share registered direct offering at $5.50/share. Shares last traded down 7.7% after trading down as much as 16.6%.
Shares gained 73% Monday after reporting updated response rate... More
Vascular Biogenics (VBLT)" Provocative OvCa Data Provide Further Clinical Validation - Piper Jaffray
June 7, 2016 9:24 AM EDTPiper Jaffray analyst, Charles Duncan, noted that on Monday at ASCO'16 Vascular Biogenics Ltd (NASDAQ: VBLT) reported updated response rate and mOS results for the ongoing Phase I/II study of VB-111 in platinum-resistant ovarian cancer. Data demonstrated a 60% (9/15) response rate by CA-125 biomarker... More
